BackSumitomo Pharma , Ltd. Overview

Sumitomo Pharma , Ltd. Total Current Liabilities

Latest total current liabilities for SMDPY: $250B.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$247.92B
↑ 22.61% YoYΔ $45.72B vs prior year quarter

Peer trimmed avg / median

Loading

Sumitomo Pharma , Ltd. Total Current Liabilities History

Loading

Sumitomo Pharma , Ltd. vs. peers: Total Current Liabilities Comparison

Loading

Sumitomo Pharma , Ltd. Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sumitomo Pharma , Ltd. (SMDPY) FAQ

Sumitomo Pharma , Ltd. (SMDPY) currently reports a total current liabilities of $250B as of September 2026. That compares with $200B in the prior-year period — up 22.6% year over year. Use the charts on this page to explore Sumitomo Pharma , Ltd.'s total current liabilities history and peer comparisons.

Sumitomo Pharma , Ltd.'s total current liabilities increased from $200B to $250B — a 22.6% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sumitomo Pharma , Ltd. reported $250B in total current liabilities as of September 2026. That compares with $200B in the prior-year period — up 22.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $250B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sumitomo Pharma , Ltd., and consider following SMDPY for alerts when major investors trade the stock.